Clinical Trials

Provision Center for Biomedical Research serves as an independent research site, consistently delivering excellence in patient care and study performance that meets research requirements and builds strong relationships with physician and sponsor partners.

Listed below are Active and Upcoming Clinical Trials. “Active” status means that Provision Center for Biomedical Research is actively involved in the trial, which may or may not be accepting new patients. Active status has two types: “Active: Open to Patient Enrollment” status is in the patient recruitment phase, where patients are welcome to enroll, provided they meet the study criteria; or “Active: Closed to Patient Enrollment”, where the study is still active in collecting data, but is closed to enrolling new patients. Should patients be interested in a trial that is closed to enrollment, they may inquire about other studies where they might qualify to participate.

If you would like more information on our clinical trials or want to learn more about enrollment, please CONTACT US

Active and Upcoming Clinical Trials

Listing Title
Description


A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Study Status
Upcoming Trial
Trial Documentation:
Principal Investigator
Dr. Kunal Gada, StatCare Medical Group
Listing Category
Description


A randomized, double blinded, dose ranging, placebo-controlled, phase 2b study to evaluate the efficacy and safety of PLN-74809 (bexategrast) for the treatment of idiopathic pulmonary fibrosis (IPF)

Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Eric Weaver, StatCare Medical Group
Listing Title
Listing Category
Description


A randomized, double-blinded, placebo-controlled, phase 3 study of the efficacy and safety of inhaled Treprostinil in subjects with idiopathic pulmonary fibrosis

Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Eric Weaver, StatCare Medical Group
Listing Category
Description


An Open-label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Eric Weaver, StatCare Medical Group
Listing Category
Description


A randomized, double-blinded, placebo-controlled, multinational, phase 3 study of the efficacy and safety of inhaled Treprostinil in subjects with progressive pulmonary fibrosis

Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Eric Weaver, StatCare Medical Group
Listing Title
Description


A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ralinepag when added to pulmonary arterial hypertension(PAH) standard of care or PAH-specific background oral therapy in subjects with World Health Organization(WHO) Group 1 pulmonary hypertension(ADVANCE Outcomes)

Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. John Swisher, StatCare Medical Group
Description


A Study Evaluating the Long-term Efficacy and Safety of Ralinepag in Subjects with PAH via an Open-label Extension (ADVANCE- Extension)

Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. John Swisher, StatCare Medical Group
Listing Category
Description


A Study of Remternetug Versus Placebo in Early Alzheimer’s Disease Participants at Risk for Cognitive and Functional Decline

Study Status
Active: Open to Patient Enrollment
Trial Documentation:
Principal Investigator
Dr. Monica Crane, Genesis Neuroscience Clinic
Listing Title
Description


MASTER SCREENING STUDY TO DETERMINE INDIVIDUALS WITH POTENTIAL TRIAL ELIGIBILITY FOR ALZHEIMER’S DISEASE STUDIES AS ASSESSED BY BIOMARKER STATUS AND COGNITION

Study Status
Upcoming Trial
Principal Investigator
Dr. Monica Crane, Genesis Neuroscience Clinic
Description


A PHASE  III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY STUDY  OF TRONTINEMAB IN PATIENTS  WITH EARLY ALZHEIMER’S DISEASE(MCI TO MILD DEMENTIA DUE TO AD)

Study Status
Upcoming Trial
Principal Investigator
Dr. Monica Crane, Genesis Neuroscience Clinic
Scroll to Top